Subscribe to Get Prostate Cancer News

Subscribe

HotSheets by Year

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001

HotSheets 2007

January February March April May June July August September October November December

January | Newsletter

President’s Message: Taking Action in 2007
Feb Conf Call: "Intimacy & Prostate Cancer"
Companies, Chapters Signing Up for Sneakers@Work Day
New Tests of Dendreon’s Prostate Cancer
Doc Moyad’s What Works and What is Worthless Column: Vitamin D—Part II
Read more..

February | Newsletter

President’s Message: “What Is Awareness?
Special Thanks to Joe Piper
The Year in Prostate Cancer: Part I of II
Doc Moyad’s What Works and What is Worthless Column: Vitamin D—Part III
Feb. 13th Conference Call:
Intimacy & Prostate Cancer
2nd Annual Us TOO Online Auction
Announced, Seeking Donated Items for Bid
Read more..

March | Newsletter

Survivor Rate Highest with Prostatectomy for Localized Prostate Cancer
New Members for Us TOO Board of Directors
The Year in Prostate Cancer, Part II
Medicare Part D and Erectile Dysfunction
Leading by Example
PROVENGE^® Granted FDA Priority Review
Read more..

April | Newsletter

Special Burning Issues Supplement: Highlights from the 2007 Multidisciplinary Prostate Cancer Symposium - February 21-24, 2007, Orlando, FL
GPC Biotech Provides Satraplatin for Free
Calcitriol with Docetaxel Boosts Survival
The Year in Prostate Cancer - Part 3
Estrogen Therapy: DES (Diethylstilbestrol)
Doc Moyad’s What Works and What is Worthless Column: Zinc supplementation?
Read more..

May | Newsletter

Special Burning Issues Supplement: Prostate cancer and incontinence: coping strategies and treatment options
MRI in Managing Prostate Cancer
FDA Panel Backs New Prostate Vaccine
Adjuvant ADT Can “Cure” Nonmetastasized Prostate Cancer
Alendronate Increases BMD in Prostate Cancer Patients Receiving ADT
Doc Moyad’s What Works and What is Worthless Column—Lycopene
Read more..

June | Newsletter

Doc Moyad’s What Works and What is Worthless Column—Provenge®
Cell Genesis Reports Phase II Results with GVAX Immunotherapy
A Survivor Reviews the 2007 ASCO Prostate Cancer Symposium
UCSD Researchers Report Ability to Detect Cancer at Earliest, Curable Stage
New Blood Test for Prostate Cancer—Can EPCA-2 be on the Horizon?
Possible New Cancer Treatment? Antifungal Drug Stops Blood Vessel Growth
Read more..

July | Newsletter

New AUA Prostate Cancer Guidelines
FDA Requirements for Provenge^® Licensure
Consider Source of Localized Prostate Cancer Recommendations
Dendreon Sued after Provenge’s Ok Put Off
²²³Radium in Hormone-Refractory Cancer
Update:Outcomes with Primary Therapy for Intermediate Risk Prostate Cancer
Read more..

August | Newsletter

New Data from ASCO on SPARC Trial
Us TOO University in Austin, Texas “A Marvelous Evening”
Survivorship Care Plan Is an Important Part of Cancer Care
Sneakers@ Work Day, Great Fun, Great Success
F-18 Fluor Choline PET/CT Assesses Bone Metastases in Prostate Cancer
New Procedure Minimizes Post-Prostatectomy Incontinence
Read more..

September | Newsletter

Court Sees No Right to Unapproved Drugs
FDA Requests More Data on Satraplatin
Hormone Inhibitor Promising For Hard-to-Treat Prostate Cancer
FDA Sued Over Provenge Delay
Botox for Treating Prostate Problems
Doc Moyad’s “No Bogus Science” Column
Friday the 13th Lucky for Prostate Pointers
Read more..

October | Newsletter

CMS Proposal Would Virtually Eliminate Medicare Clinical Trials Coverage
Statins Fail to Cut the Androgens that Fuel Prostate Cancer
Stress Management before Prostatectomy
First Biomarker Discovered that Predicts Prostate Cancer Outcome
Prostate Px® Test Results Published
Doc Moyad’s What Works and What is Worthless Column
Read more..

November | Newsletter

Charity Navigator Gives Us TOO 4-Star Rating
Gleason Score and Prostate Cancer Prognosis
New Study Refutes Belief that Black Men Have More Aggressive Prostate Cancer
Us TOO Reaches Out to Federal Employees and Military
Nomogram Can Predict Life Expectancy
oc Moyad’s What Works and What is Worthless Column—Ginseng
Read more..

December | Newsletter

Us TOO’s 2006 Annual Report Now Available
New Free Kits for Newly-Diagnosed Men
Survival Analysis from the SPARC Trial
Us TOO University Chicago Program a Success
October 30th Intimacy Teleconference a Success
Biopsy Site Affects Prostate Cancer Detection
Read more..